Penumbra, Inc Stock-Based Compensation
Penumbra, Inc (PEN) reported Stock-Based Compensation of $28.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-07-30
- Penumbra, Inc share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $13.66M, a 4.04% decline year-over-year.
- Penumbra, Inc share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $14.64M, a 6.24% increase year-over-year.
- Penumbra, Inc share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $15.26M, a 26.18% increase year-over-year.
- Penumbra, Inc share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $15.93M, a 45.63% increase year-over-year.
- Penumbra, Inc share-based payment arrangement, noncash expense for fiscal 2025 was $59.21M, a 28.27% increase from fiscal 2024.
- Penumbra, Inc share-based payment arrangement, noncash expense for fiscal 2024 was $46.16M, a 8.62% decline from fiscal 2023.
- Penumbra, Inc share-based payment arrangement, noncash expense for fiscal 2023 was $50.52M, a 35.15% increase from fiscal 2022.
- Penumbra, Inc share-based payment arrangement, noncash expense for fiscal 2022 was $37.38M, a 43.16% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $13.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $28.30M 10-Q · filed 2026-07-30 | $43.57M derived: sum of 3 quarters · filed 2026-07-30 | $59.50M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $14.64M 10-Q · filed 2026-05-06 | $29.91M derived: sum of 2 quarters · filed 2026-05-06 | $45.84M derived: sum of 3 quarters · filed 2026-05-06 | $60.07M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $15.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $31.19M derived: sum of 2 quarters · filed 2026-02-25 | $45.43M derived: sum of 3 quarters · filed 2026-07-30 | $59.21M 10-K · filed 2026-02-25 |
| 2025-09-30 | $15.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $30.17M derived: sum of 2 quarters · filed 2026-07-30 | $43.95M 10-Q · filed 2025-11-05 | $56.05M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $14.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $28.02M 10-Q · filed 2026-07-30 | $40.11M derived: sum of 3 quarters · filed 2026-07-30 | $51.05M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $13.79M 10-Q · filed 2026-05-06 | $25.88M derived: sum of 2 quarters · filed 2026-05-06 | $36.82M derived: sum of 3 quarters · filed 2026-05-06 | $46.38M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $12.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $23.04M derived: sum of 2 quarters · filed 2026-02-25 | $32.59M derived: sum of 3 quarters · filed 2026-02-25 | $46.16M 10-K · filed 2026-02-25 |
| 2024-09-30 | $10.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $20.50M derived: sum of 2 quarters · filed 2025-11-05 | $34.07M 10-Q · filed 2025-11-05 | $44.86M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $9.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $23.13M 10-Q · filed 2025-07-29 | $33.92M derived: sum of 3 quarters · filed 2026-02-25 | $48.06M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $13.57M 10-Q · filed 2025-04-23 | $24.36M derived: sum of 2 quarters · filed 2026-02-25 | $38.50M derived: sum of 3 quarters · filed 2026-02-25 | $51.32M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $10.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $24.93M derived: sum of 2 quarters · filed 2026-02-25 | $37.75M derived: sum of 3 quarters · filed 2026-02-25 | $50.52M 10-K · filed 2026-02-25 |
| 2023-09-30 | $14.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $26.96M derived: sum of 2 quarters · filed 2024-10-30 | $39.73M 10-Q · filed 2024-10-30 | $49.72M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $12.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $25.59M 10-Q · filed 2024-07-30 | $35.59M derived: sum of 3 quarters · filed 2025-02-18 | $45.29M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $12.77M 10-Q · filed 2024-05-07 | $22.76M derived: sum of 2 quarters · filed 2025-02-18 | $32.47M derived: sum of 3 quarters · filed 2025-02-18 | $41.25M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $19.70M derived: sum of 2 quarters · filed 2025-02-18 | $28.48M derived: sum of 3 quarters · filed 2025-02-18 | $37.38M 10-K · filed 2025-02-18 |
| 2022-09-30 | $9.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $18.49M derived: sum of 2 quarters · filed 2023-11-02 | $27.38M 10-Q · filed 2023-11-02 | $69.04M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $8.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $17.68M 10-Q · filed 2023-08-01 | $59.34M derived: sum of 3 quarters · filed 2024-02-22 | $67.24M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $8.89M 10-Q · filed 2023-05-02 | $50.55M derived: sum of 2 quarters · filed 2024-02-22 | $58.46M derived: sum of 3 quarters · filed 2024-02-22 | $68.26M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $41.66M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $49.56M derived: sum of 2 quarters · filed 2024-02-22 | $59.37M derived: sum of 3 quarters · filed 2024-02-22 | $65.76M 10-K · filed 2024-02-22 |
| 2021-09-30 | $7.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $17.71M derived: sum of 2 quarters · filed 2022-11-03 | $24.10M 10-Q · filed 2022-11-03 | $32.16M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $9.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $16.20M 10-Q · filed 2022-08-05 | $24.25M derived: sum of 3 quarters · filed 2023-02-23 | $30.49M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $6.39M 10-Q · filed 2022-05-03 | $14.45M derived: sum of 2 quarters · filed 2023-02-23 | $20.69M derived: sum of 3 quarters · filed 2023-02-23 | $26.25M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $8.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $14.29M derived: sum of 2 quarters · filed 2023-02-23 | $19.85M derived: sum of 3 quarters · filed 2023-02-23 | $25.54M 10-K · filed 2023-02-23 |
| 2020-09-30 | $6.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $11.80M derived: sum of 2 quarters · filed 2021-11-03 | $17.49M 10-Q · filed 2021-11-03 | $22.50M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $5.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $11.25M 10-Q · filed 2021-08-09 | $16.26M derived: sum of 3 quarters · filed 2022-02-22 | $22.50M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $5.69M 10-Q · filed 2021-05-04 | $10.70M derived: sum of 2 quarters · filed 2022-02-22 | $16.94M derived: sum of 3 quarters · filed 2022-02-22 | $22.08M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $5.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $11.26M derived: sum of 2 quarters · filed 2022-02-22 | $16.39M derived: sum of 3 quarters · filed 2022-02-22 | $21.48M 10-K · filed 2022-02-22 |
| 2019-09-30 | $6.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $11.38M derived: sum of 2 quarters · filed 2020-11-02 | $16.47M 10-Q · filed 2020-11-02 | $21.34M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $5.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $10.23M 10-Q · filed 2020-08-03 | $15.10M derived: sum of 3 quarters · filed 2021-02-23 | $19.51M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $5.09M 10-Q · filed 2020-05-07 | $9.97M derived: sum of 2 quarters · filed 2021-02-23 | $14.38M derived: sum of 3 quarters · filed 2021-02-23 | $19.36M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $4.87M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $9.28M derived: sum of 2 quarters · filed 2021-02-23 | $14.27M derived: sum of 3 quarters · filed 2021-02-23 | $18.42M 10-K · filed 2021-02-23 |
| 2018-09-30 | $4.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $9.40M derived: sum of 2 quarters · filed 2019-11-07 | $13.55M 10-Q · filed 2019-11-07 | $18.27M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $4.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $9.14M 10-Q · filed 2019-08-06 | $13.86M derived: sum of 3 quarters · filed 2020-02-26 | $18.35M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $4.15M 10-Q · filed 2019-05-07 | $8.87M derived: sum of 2 quarters · filed 2020-02-26 | $13.36M derived: sum of 3 quarters · filed 2020-02-26 | $17.95M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $4.72M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $9.21M derived: sum of 2 quarters · filed 2020-02-26 | $13.80M derived: sum of 3 quarters · filed 2020-02-26 | $17.81M 10-K · filed 2020-02-26 |
| 2017-09-30 | $4.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $9.08M derived: sum of 2 quarters · filed 2018-11-05 | $13.09M 10-Q · filed 2018-11-05 | $16.93M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $4.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $8.61M 10-Q · filed 2018-08-07 | $12.44M derived: sum of 3 quarters · filed 2019-02-26 | $16.70M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $4.01M 10-Q · filed 2018-05-08 | $7.85M derived: sum of 2 quarters · filed 2019-02-26 | $12.11M derived: sum of 3 quarters · filed 2019-02-26 | $15.63M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $8.10M derived: sum of 2 quarters · filed 2019-02-26 | $11.62M derived: sum of 3 quarters · filed 2019-02-26 | $14.64M 10-K · filed 2019-02-26 |
| 2016-09-30 | $4.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $7.79M derived: sum of 2 quarters · filed 2017-11-07 | $10.80M 10-Q · filed 2017-11-07 | $12.95M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $3.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $6.54M 10-Q · filed 2017-08-08 | $8.68M derived: sum of 3 quarters · filed 2018-02-27 | $10.19M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $3.02M 10-Q · filed 2017-05-09 | $5.16M derived: sum of 2 quarters · filed 2018-02-27 | $6.67M derived: sum of 3 quarters · filed 2018-02-27 | $9.93M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $3.65M derived: sum of 2 quarters · filed 2018-02-27 | $6.92M derived: sum of 3 quarters · filed 2018-02-27 | $7.27M 10-K · filed 2018-02-27 |
| 2015-09-30 | $1.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $4.77M derived: sum of 2 quarters · filed 2016-11-03 | $5.13M 10-Q · filed 2016-11-03 | $5.49M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $3.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $3.62M 10-Q · filed 2016-08-09 | $3.98M derived: sum of 3 quarters · filed 2017-02-28 | |
| 2015-03-31 | $355.00K 10-Q · filed 2016-05-09 | $714.00K derived: sum of 2 quarters · filed 2017-02-28 | ||
| 2014-12-31 | $359.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $1.43M 10-K · filed 2017-02-28 | ||
| 2014-09-30 | $1.07M 10-Q · filed 2015-11-12 | |||
| 2013-12-31 | $886.00K 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |